Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement. This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added.

PTI | New Delhi | Updated: 23-07-2020 14:46 IST | Created: 23-07-2020 14:46 IST
Delhi-based Dr Dangs selected as central lab for Covaxin human clinical trials

A Delhi-based private laboratory has claimed that it has been selected as the central lab for human clinical trials of Covaxin, India's indigenous COVID-19 vaccine candidate. The vaccine is being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

Dr. Dangs Lab said on Wednesday that it has partnered with Bharat Biotech for conducting the trials. "We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin; India's indigenous COVID-19 vaccine being developed and manufactured by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV)," it said in a statement.

This is a "randomised, double blind, placebo controlled multi-centric clinical trial in India", it added. "Dr. Dangs Lab is currently processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune)," the statement said.

The lab has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing and will be increasing operations as per assigned timelines to cover 12 sites across the length and breadth of the country over this month, it added. "Stringent quality norms driven by good clinical laboratory practice (GCLP) guidelines are being followed as mandated by regulatory authorities. The lab has renowned experts in each field who are working tirelessly and collectively to provide quality and timely results to fulfil the imminent need of an effective and safe COVID19 vaccine," the statement said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

East African women traders: 'Celebrating the past, planning for the future'

COVID-19 has hit women disproportionately hard across East Africa, especially those working in the informal sector. Lessons must be learnt to prevent this from happening again....

Viral variants and vaccine nationalism pose two-pronged threat to Covid victory

... ...

Tracking Fintech during COVID-19: Harnessing power of technology

Its abundantly clear now that as fintech cements its place in the financial sector, accelerated further by the COVID-19 pandemic, it could open the sector to new possibilities by harnessing the power of technology to deliver financial ...

Tectonic turns: How technology shaped healthcare over the decades

Tracing an episodic evolution, with technology at the interface of human and his health....

Videos

Latest News

FIR lodged against suspended SHO, SSI; police raiding possible hideouts

An FIR has been lodged under the Prevention of Corruption Act and for alleged dereliction of duty at the Bhojpur police station here against suspended SHO Pradeep Kumar and SSI Shakeel Ahmed. The FIR was lodged by officiating SHO Shailendra...

AISA alleges COVID-19 positive JNU students isolated 'without proper care'

The All India Students Association on Wednesday alleged that the Jawaharlal Nehru University administration has put COVID-infected students at an isolation centre without proper care.The students association alleged in a statement that ther...

Senate Republican says U.S. police reform proposal may be done in week or two

One day after a Minnesota jury convicted a former police officer for the murder of George Floyd, Republican U.S. Senator Tim Scott said on Wednesday he may be finished with drafting a proposal for a policing reform bill in the next week or ...

Return the favor: S.Korea looks to U.S. for COVID-19 vaccine aid

South Korea hopes its ally the United States will help it tackle a shortage of coronavirus vaccine in return for test kits and masks Seoul sent to Washington earlier in the pandemic, the foreign minister said on Wednesday. The government ha...

Give Feedback